Anti-SERF1A monoclonal antibody

Pre-made anti-SERF1A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SERF1A/SERF1A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1610-Ab-1/ GM-Tg-hg-IP1610-Ab-2Anti-Human SERF1A monoclonal antibodyHuman
GM-Tg-rg-IP1610-Ab-1/ GM-Tg-rg-IP1610-Ab-2Anti-Rat SERF1A monoclonal antibodyRat
GM-Tg-mg-IP1610-Ab-1/ GM-Tg-mg-IP1610-Ab-2Anti-Mouse SERF1A monoclonal antibodyMouse
GM-Tg-cynog-IP1610-Ab-1/ GM-Tg-cynog-IP1610-Ab-2Anti-Cynomolgus/ Rhesus macaque SERF1A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1610-Ab-1/ GM-Tg-felg-IP1610-Ab-2Anti-Feline SERF1A monoclonal antibodyFeline
GM-Tg-cang-IP1610-Ab-1/ GM-Tg-cang-IP1610-Ab-2Anti-Canine SERF1A monoclonal antibodyCanine
GM-Tg-bovg-IP1610-Ab-1/ GM-Tg-bovg-IP1610-Ab-2Anti-Bovine SERF1A monoclonal antibodyBovine
GM-Tg-equg-IP1610-Ab-1/ GM-Tg-equg-IP1610-Ab-2Anti-Equine SERF1A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1610-Ab-1/ GM-Tg-hg-IP1610-Ab-2; GM-Tg-rg-IP1610-Ab-1/ GM-Tg-rg-IP1610-Ab-2;
GM-Tg-mg-IP1610-Ab-1/ GM-Tg-mg-IP1610-Ab-2; GM-Tg-cynog-IP1610-Ab-1/ GM-Tg-cynog-IP1610-Ab-2;
GM-Tg-felg-IP1610-Ab-1/ GM-Tg-felg-IP1610-Ab-2; GM-Tg-cang-IP1610-Ab-1/ GM-Tg-cang-IP1610-Ab-2;
GM-Tg-bovg-IP1610-Ab-1/ GM-Tg-bovg-IP1610-Ab-2; GM-Tg-equg-IP1610-Ab-1/ GM-Tg-equg-IP1610-Ab-2
Products NameAnti-SERF1A monoclonal antibody
Formatmab
Target NameSERF1A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SERF1A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1610-Ag-1Recombinant multi-species SERF1/ SERF1A/ 4F5 protein


    Target information

    Target IDGM-IP1610
    Target NameSERF1A
    Gene ID8293,502503,106998801
    Gene Symbol and Synonyms4F5,FAM2A,H4F5,RGD1565105,SERF1,SERF1A,SMAM1
    Uniprot AccessionO75920
    Uniprot Entry NameSERF1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseBreast Cancer
    Gene EnsemblENSG00000172058
    Target ClassificationN/A

    The target: SERF1A, gene name: SERF1A, also named as 4F5, FAM2A, H4F5, SERF1, SMAM1. This gene is part of a 500 kb inverted duplication on chromosome 5q13. This duplicated region contains at least four genes and repetitive elements which make it prone to rearrangements and deletions. The repetitiveness and complexity of the sequence have also caused difficulty in determining the organization of this genomic region. The duplication region includes both a telomeric and a centromeric copy of this gene. Deletions of this gene, the telomeric copy, often accompany deletions of the neighboring SMN1 gene in spinal muscular atrophy (SMA) patients, and so it is thought that this gene may be a modifier of the SMA phenotype. The function of this protein is not known; however, it bears low-level homology with the RNA-binding domain of matrin-cyclophilin, a protein which colocalizes with small nuclear ribonucleoproteins (snRNPs) and the SMN1 gene product. Alternatively spliced transcripts have been documented but it is unclear whether alternative splicing occurs for both the centromeric and telomeric copies of the gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.